We’re excited to share that Q-Centrix has joined MRO, a leader in clinical data exchange.

See IP Clinical Data
Differently

Part of a comprehensive Quality Measurement & Improvement solution, Q-Centrix’s Infection Prevention (IP) partnership options focus on maximizing investment and reducing the risk of financial penalties with the highest fidelity data. With timely, accurate, and consistent HAI surveillance and NHSN reporting, Q-Centrix empowers on-site IPs to perform at top of license to reduce infections.

Prevent Infections Before They Occur

Keeping up with ongoing positive culture review and public reporting can be tedious and time-consuming. Give on-site IP teams the time to complete prevention and rounding while Q-Centrix’s IPs perform HAI surveillance in near real-time to identify and notify facilities of HAIs.

Q-Centrix’s infection surveillance solution includes screening:

  • Surgical Site Infections (SSI)
  • Central Line Associated Blood Stream Infections (CLABSI)
  • Catheter Associated Urinary Tract Infections (CAUTI)
  • C.diff & MRSA Bacteremia Laboratory-Identified Events (LabID)
  • Ventilator Associated Events (VAE)

100%

of IPs are certified in Infection Prevention

100%

of IPs have been provided Hospital Infection Prevention, Quality, or related trainings

50%

of IPs hold advanced degrees while 100% hold a Bachelor’s degree

132,000+

IP cases abstracted annually

Flexible Partnership Options

All-In HAI Surveillance

Q-Centrix’s team of dedicated IP experts complete comprehensive HAI surveillance, with the option of NHSN reporting and management.

Resource-Driven Support

Q-Centrix’s dedicated IP experts assume responsibility for the most time-consuming portions of HAI surveillance and can optionally complete NHSN reporting.

HAI Problem-Focused

Focused on decreasing high-risk HAIs when infections are problematic or rising, Q-Centrix’s dedicated IP experts identify targeted HAIs in near real-time and notify local IP staff.

See how Q-Centrix can optimize your IP performance